ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
C600003295 |
|
174350-06-2 |
174350-06-2 - 98% |
0 | C22H32F2 | |
C600003294 |
|
6870-94-6 |
6870-94-6 - 98% |
0 | — | |
C600003293 |
|
174350-08-4 |
(trans,trans)-4-(2,3-Difluoro-4-methylphenyl)-4'-ethyl-1,1'-bi(cyclohexane) - 98% |
0 | C21 H30 F2 | |
C600003292 |
|
81936-33-6 |
4-(trans-4-Propylcyclohexyl)phenol - 98% |
0 | C15 H22 O | |
C600003291 |
|
208338-50-5 |
(trans,trans)-4-(Difluoro(3,4,5-trifluorophenoxy)methyl)-4'-propyl-1,1'-bi(cyclohexane) - 98% |
0 | C22 H29 F5 O | |
C600003290 |
|
135206-87-0 |
(R)-2-Hydroxy-1-morpholinopropan-1-one - 98% |
0 | C7 H13 N O3 | |
C600003289 |
|
89100-78-7 |
4-(trans-4-Ethylcyclohexyl)phenol - 98% |
0 | C14 H20 O | |
C600003288 |
|
124728-81-0 |
TRANS,TRANS-4''-(4-ETHOXY-2,3-DIFLUORO-PHENYL)-4-PENTYL-BICYCLOHEXYL - 98% |
0 | C25 H38 F2 O | |
C600003287 |
|
916156-32-6 |
916156-32-6 - 98% |
0 | C30H22F8O | |
C600003286 |
|
1700-02-3 |
2,4-Dichloro-6-phenyl-1,3,5-triazine - 98% |
0 | C9 H5 Cl2 N3 | |
C600003285 |
|
1110813-31-4 |
Dacomitinib - 98% |
0 | C24 H25 Cl F N5 O2 | |
C600003284 |
|
123560-48-5 |
TRANS,TRANS-4''-(4-ETHOXY-2,3-DIFLUORO-PHENYL)-4-PROPYL-BICYCLOHEXYL - 98% |
0 | C23 H34 F2 O | |
C600003283 |
|
3842-55-5 |
2-Chloro-4,6-diphenyl-1,3,5-triazine - 98% |
0 | C15 H10 Cl N3 | |
C600003282 |
|
55496-69-0 |
4-Chloro-7-methoxy-6-nitroquinazoline - 98% |
0 | C9 H6 Cl N3 O3 | |
C600003281 |
|
174079-87-9 |
1-(4-methoxyphenyl cyclohexyl)-2-(4-vinyl cyclohexyl)ethylene - 98% |
0 | C23H32O | |
C600003280 |
|
864377-31-1 |
2-(3-Bromophenyl)-4,6-diphenyl-1,3,5-triazine - 98% |
0 | C21 H14 Br N3 | |
C600003279 |
|
253199-08-5 |
Trans,trans-4-(4-Ethoxy-2,3-difluorophenyl)-4'-ethyl-1,1'-bi(cyclohexane) - 98% |
0 | C22 H32 F2 O | |
C600003278 |
|
75665-73-5 |
N/A - 98% |
0 | C16 H17 N O3 | |
C600003277 |
|
23449-08-3 |
2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine - 98% |
0 | C21 H14 Br N3 | |
C600003276 |
|
914087-74-4 |
914087-74-4 - 98% |
0 | C29H20F8O | |